UNODC confirms that the synthetic drug market in East and Southeast Asia has adapted to setbacks brought on by Covid-19, with production and trafficking surging once again.

SAT provides a contemporary overview of HIV prevention funding in Southern Africa in order to support efforts towards ending the epidemic.

The EMCDDA analyses trends and developments in the region's drug situation and related health provisions.

The EU Civil Society Forum on Drugs lays out guidelines on how to make the involvement of civil society in drug policy more meaningful.

EHRA publishes the results of its survey on OST in order to develop practical recommendations that will help decision-makers and health providers to refine their approaches on the subject.

The 1st Brandenburg Forum provided a trusted space for important discussion and debate to strengthen the drug policy focus within the key health and human rights bodies in Geneva.

The UN WGAD documents widespread human rights violations associated with the "war on drugs" leading to increased arbitrary detention.

HIV Policy Lab has compiled a policy brief highlighting seven laws and policies that countries should adopt to markedly reduce AIDS-related mortality figures by 2030.

Santo Jr. et al. offer further evidence on OAT's crucial role in prolonging and sustaining the lives of people with opioid dependence.

UNAIDS urges world leaders to adopt a bold political declaration on HIV at the United Nations General Assembly High-Level Meeting on AIDS.

CIVICUS sheds light on worsening conditions for the work of civil society, exacerbated by restrictions expanded during the COVID-19 pandemic.

Dennis proposes considering the dramatic increase in drug deaths among older people in Britain as a failure in response-ability, urging for more caring, evidence-based and respectful responses.

WHO highlights progress, shortfalls and actions needed to achieve 2030 goals, including in terms of addressing sociostructural barriers to health, such as stigma and criminalisation.

MENAHRA presents an in-depth review of the development harm reduction responses in the region over the past decade.

Civil society calls on the UN General Assembly to commit to fair and unobstructed access to health and harm reduction services.

EHRA provides a series of recommendations for those who seek to offer professional, comprehensive care for women who use drugs and experience gender-based violence (GBV).

McDonald et al. suggest that age-focused explanations are insufficient to account for skyrocketing drug-related deaths, and call for an expansion of harm reduction provision.

C-EHRN provides advice to reduce the harms associated with the unintentional consumption of synthetic cannabinoids in contexts where drug checking services are not available.

Youth RISE lays out the key issues that need tackling for young people who use drugs and other inadequately served populations to benefit from UHC.

The UN system makes recommendations aimed at improving prison conditions and reducing prison populations.